Dr. Anna L. Cogen, MD, PhD

Dr. Cogen practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Dr. Cogen's NPI, 1669869491, was assigned on April 20, 2015. Dr. Cogen graduated from University of California, San Francisco School of Medicine in 2015. Dr. Cogen holds Washington license MD60951292.

Dr. Cogen's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Dr. Cogen's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Cogen is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cogen practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Cogen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cogen is licensed in Washington.

CMS data shows 857 Medicare services from Dr. Cogen across 12 procedure codes in 2024, for 232 Medicare patients. Medicare paid $29,730 for them.

CMS counts 232 Medicare patients who saw Dr. Cogen in 2024. The largest group is 65 to 74, with 100 patients. 65% of them have high blood pressure, and 64% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cogen's median patient age at 67, with 57% women.

In 2024, Dr. Cogen wrote 332 Medicare Part D claims for 91 patients. 93% of them were for generic drugs. CMS names the drug for 208 of them, across 8 drugs with 11 or more claims each, at $105,525 in total drug cost. In 2023, CMS named 255 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Cogen for performance year 2024, reported through an alternative payment model (APM). Dr. Cogen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cogen as offering telehealth. CMS counts 195 procedures of removal of skin lesions by Dr. Cogen, more than 79% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Cogen, published from 2010 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Biopsy, Cells, Cultured and Keratinocytes. Dr. Cogen has published most often in Am J Trop Med Hyg. Dr. Cogen's most frequent co-authors are Benjamin Harris Kaffenberger, MD, Arash Mostaghimi, MD, MPA, MPH and Afsaneh Alavi, MD.

CMS Open Payments shows 2 general payments to Dr. Cogen from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $136.

Dr. Cogen graduated from University of California, San Francisco School of Medicine in 2015.